Variant report
Variant | esv3365390 |
---|---|
Chromosome Location | chr8:69442447-69470709 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:36)
- CpG islands (count:0)
- Chromatin interactive region (count:7)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:36 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BACH1 | chr8:69468596-69469028 | H1-hESC | embryonic stem cell: | n/a | n/a |
2 | E2F4 | chr8:69455525-69455763 | MCF10A-Er-Src | breast: | n/a | chr8:69455527-69455536 |
3 | EP300 | chr8:69451305-69451465 | K562 | blood: | n/a | n/a |
4 | FOXA1 | chr8:69459934-69460222 | ECC-1 | luminal epithelium: | n/a | n/a |
5 | FOXA1 | chr8:69459941-69460164 | ECC-1 | luminal epithelium: | n/a | n/a |
6 | GATA3 | chr8:69459823-69460344 | MCF-7 | breast: | n/a | n/a |
7 | GATA3 | chr8:69462868-69463057 | SH-SY5Y | brain: | n/a | n/a |
8 | KAP1 | chr8:69445140-69445419 | K562 | blood: | n/a | n/a |
9 | KAP1 | chr8:69459867-69460312 | HEK293 | kidney: | n/a | n/a |
10 | MAFF | chr8:69468641-69468943 | HepG2 | liver: | n/a | chr8:69468790-69468808 |
11 | MAFF | chr8:69463354-69463489 | HepG2 | liver: | n/a | n/a |
12 | MAFK | chr8:69443274-69443399 | HepG2 | liver: | n/a | chr8:69443303-69443318 |
13 | MAFK | chr8:69463418-69463448 | HepG2 | liver: | n/a | n/a |
14 | MAFK | chr8:69468612-69468924 | HepG2 | liver: | n/a | chr8:69468792-69468802 chr8:69468793-69468802 chr8:69468791-69468806 |
15 | MAFK | chr8:69463364-69463490 | HepG2 | liver: | n/a | chr8:69463414-69463429 |
16 | MAFK | chr8:69468618-69468996 | H1-hESC | embryonic stem cell: | n/a | chr8:69468792-69468802 chr8:69468793-69468802 chr8:69468791-69468806 |
17 | MAFK | chr8:69443282-69443376 | HepG2 | liver: | n/a | chr8:69443303-69443318 |
18 | MAFK | chr8:69468617-69468947 | HepG2 | liver: | n/a | chr8:69468792-69468802 chr8:69468793-69468802 chr8:69468791-69468806 |
19 | MAFK | chr8:69468695-69468919 | IMR90 | lung: | n/a | chr8:69468792-69468802 chr8:69468793-69468802 chr8:69468791-69468806 |
20 | NR2F2 | chr8:69459866-69460354 | MCF-7 | breast: | n/a | n/a |
21 | POLR2A | chr8:69459661-69460374 | PFSK-1 | brain: | n/a | n/a |
22 | POLR2A | chr8:69448135-69448153 | MCF10A-Er-Src | breast: | n/a | n/a |
23 | POLR2A | chr8:69451832-69451974 | H1-hESC | embryonic stem cell: | n/a | n/a |
24 | POLR2A | chr8:69450263-69450428 | MCF10A-Er-Src | breast: | n/a | n/a |
25 | POLR2A | chr8:69453614-69453693 | MCF-7 | breast: | n/a | n/a |
26 | POLR2A | chr8:69468109-69468309 | MCF10A-Er-Src | breast: | n/a | n/a |
27 | POLR2A | chr8:69468808-69468916 | H1-hESC | embryonic stem cell: | n/a | n/a |
28 | POLR2A | chr8:69442753-69442889 | MCF10A-Er-Src | breast: | n/a | n/a |
29 | POLR2A | chr8:69455869-69455881 | MCF10A-Er-Src | breast: | n/a | n/a |
30 | POLR2A | chr8:69468825-69468912 | A549 | lung: | n/a | n/a |
31 | POLR2A | chr8:69454587-69454602 | MCF10A-Er-Src | breast: | n/a | n/a |
32 | POLR2A | chr8:69468822-69468939 | MCF-7 | breast: | n/a | n/a |
33 | TAF1 | chr8:69459894-69460278 | PFSK-1 | brain: | n/a | n/a |
34 | TCF7L2 | chr8:69459854-69460387 | HEK293 | kidney: | n/a | n/a |
35 | TCF7L2 | chr8:69459977-69460276 | Hela-S3 | cervix: | n/a | n/a |
36 | ZNF143 | chr8:69463154-69463263 | H1-hESC | embryonic stem cell: | n/a | n/a |
No data |
(count:7 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:69441306..69443760-chr8:69445499..69448302,2 | MCF-7 | breast: | |
2 | chr8:69463749..69466393-chr8:69471185..69473113,2 | MCF-7 | breast: | |
3 | chr8:69441306..69443760-chr8:69445499..69448302,2 | MCF-7 | breast: | |
4 | chr8:69455782..69457817-chr8:69462101..69463881,2 | K562 | blood: | |
5 | chr8:69455782..69457817-chr8:69462101..69463881,2 | K562 | blood: | |
6 | chr8:69440806..69442992-chr8:69446765..69449048,2 | K562 | blood: | |
7 | chr8:69440806..69442992-chr8:69446765..69449048,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
C8orf34 | TF binding region |
RPS15AP25 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs187145554 | chr8:69442477-69442478 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs368263371 | chr8:69442525-69442526 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs557101105 | chr8:69442527-69442528 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs377337945 | chr8:69442532-69442533 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs144939841 | chr8:69442554-69442555 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs4559226 | chr8:69442583-69442584 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs4455810 | chr8:69442613-69442614 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
8 | rs191020329 | chr8:69442630-69442631 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs4559227 | chr8:69442652-69442653 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs56048834 | chr8:69442819-69442820 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs530991269 | chr8:69442867-69442868 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs539874274 | chr8:69442924-69442925 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs182127092 | chr8:69442945-69442946 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs575332476 | chr8:69442950-69442951 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs569820928 | chr8:69443033-69443034 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs138825091 | chr8:69443111-69443112 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs552179384 | chr8:69443140-69443141 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs186724746 | chr8:69443162-69443163 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs534302904 | chr8:69443187-69443188 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs142006343 | chr8:69443219-69443220 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs567832042 | chr8:69443265-69443266 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs557839463 | chr8:69443293-69443294 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs536710971 | chr8:69443323-69443324 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs2380475 | chr8:69443329-69443330 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs577355306 | chr8:69443340-69443341 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs371590843 | chr8:69443361-69443362 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs11992254 | chr8:69443370-69443371 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs553367412 | chr8:69443375-69443376 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs191534931 | chr8:69443413-69443414 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs7009978 | chr8:69443476-69443477 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs183046484 | chr8:69443516-69443517 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs188480836 | chr8:69443520-69443521 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs575811592 | chr8:69443542-69443543 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs7009743 | chr8:69443554-69443555 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs79611902 | chr8:69443566-69443567 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs143697951 | chr8:69443608-69443609 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs575720554 | chr8:69443612-69443613 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs148126024 | chr8:69443618-69443619 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs112083265 | chr8:69443624-69443625 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs559411023 | chr8:69443640-69443641 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs541804425 | chr8:69443664-69443665 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs113929703 | chr8:69443695-69443696 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs150669199 | chr8:69443696-69443697 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs192896705 | chr8:69443749-69443750 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs550243590 | chr8:69443831-69443832 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs571050430 | chr8:69443839-69443840 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs539665527 | chr8:69443845-69443846 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs7010609 | chr8:69443857-69443858 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs116422430 | chr8:69443894-69443895 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs536107139 | chr8:69443917-69443918 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 22183965 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Sezary syndrome | 18413736 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
head and neck squamous cell carcinoma | 16715129 | CNVD |
Prostate cancer | 16461572 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 21399628 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 22522925 | CNVD |
Colorectal cancer | 21645411 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:69423800-69445600 | Weak transcription | Aorta | Aorta |
2 | chr8:69445400-69447800 | Weak transcription | Adipose Nuclei | Adipose |
3 | chr8:69446600-69447000 | Active TSS | Primary T helper memory cells from peripheral blood 2 | blood |
4 | chr8:69460000-69460400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr8:69467200-69467800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
6 | chr8:69467200-69467800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
7 | chr8:69467400-69467600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
8 | chr8:69467400-69467800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
9 | chr8:69467400-69468400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
10 | chr8:69467800-69468800 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
11 | chr8:69467800-69468800 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
12 | chr8:69467800-69477400 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
13 | chr8:69468400-69478600 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
14 | chr8:69468600-69469000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
15 | chr8:69468600-69469000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
16 | chr8:69468800-69469000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
17 | chr8:69468800-69469000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
18 | chr8:69468800-69469600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
19 | chr8:69469600-69477400 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |